Nektar Therapeutics NKTR Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Nektar Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's quick ratio?
- Nektar Therapeutics (NKTR) reported quick ratio of 10.2× in Q1 2026.
- How has Nektar Therapeutics's quick ratio changed year-over-year?
- Nektar Therapeutics's quick ratio increased by 214.9% year-over-year, from 3.2× to 10.2×.
- What is the long-term trend for Nektar Therapeutics's quick ratio?
- Over 5 years (2020 to 2025), Nektar Therapeutics's quick ratio has grown at a -12.5% compound annual growth rate (CAGR), from 9.7× to 5×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.